MedPath

Maternal Health Diabetes Prevention Study

Not Applicable
Completed
Conditions
Glucose Intolerance During Pregnancy
Hyperglycemia
PreDiabetes
Gestational Diabetes
Interventions
Behavioral: Lifestyle Intervention
Registration Number
NCT05343494
Lead Sponsor
Tulane University
Brief Summary

The aim of this project is to use the Exploration, Preparation, Implementation, Sustainment (EPIS) framework to collect pilot data on the implementation of a Diabetes Prevention Program-like intervention in the Women, Infants, and Children (WIC) program.

Detailed Description

In this study, investigators will pilot a 2-month Diabetes Prevention Program-like program (delivered by WIC staff) to 20 women with recent gestational diabetes (6 weeks to 12 months postpartum) who receive WIC services.

The goal of this pilot is to evaluate the feasibility, acceptability, appropriateness, fidelity of implementing this intervention in the setting of WIC clinics and feasibility of conducting a larger-scale study.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
20
Inclusion Criteria
  • Age ≥18 years
  • 6 weeks to 12 months postpartum
  • Medical record documented diagnosis of GDM during most recent pregnancy
  • Access to a device that can access the internet
  • English speaking
Exclusion Criteria
  • Pregnant or planning to become pregnant in the next two months
  • Planning to move out of the area in the next two months
  • Self-report of diagnosed diabetes
  • Use of glucose-lowering medications
  • Plasma glucose >200 mg/dL and classic symptoms of hyperglycemia (thirst, polyuria, weight loss, blurry vision) or HbA1c >6.5% (based on screening visit blood draw)
  • Unable or unwilling to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Lifestyle InterventionLifestyle InterventionThe intervention has been modified from a subset of sessions from the National DPP Prevent T2 Curriculum (an adapted DPP for community settings that improves cardiometabolic outcomes and is implemented nationwide). The intervention will consist of 8 weekly sessions. The first session will be one-on-one and subsequent sessions will be in small groups. Sessions 1, 2, and 6 will be in-person and other sessions will be held by Zoom.
Primary Outcome Measures
NameTimeMethod
Fidelity - sessions attended8-week intervention

Number of sessions attended throughout the 8 week intervention

Secondary Outcome Measures
NameTimeMethod
Fidelity - sessions held8-week intervention

Number of sessions held throughout the 8 week intervention

Fidelity - session content8-week intervention

Assessment of whether key concepts were covered during sessions

Intervention feasibility2-month data collection visit

Feasibility questionnaire delivered to participants and staff delivering the intervention

Intervention appropriateness2-month data collection visit

Appropriateness questionnaire delivered to participants and staff delivering the intervention

Intervention acceptability2-month data collection visit

Acceptability questionnaire delivered to participants and staff delivering the intervention

Trial Locations

Locations (1)

Tulane Office of Health Research

🇺🇸

New Orleans, Louisiana, United States

© Copyright 2025. All Rights Reserved by MedPath